AbbVie Non-cash litigation reserve adjustments increased by 147.0% to $150.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 120.6%, from -$729.00M to $150.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Frequent large adjustments may signal ongoing legal instability or uncertainty regarding potential liabilities.
This metric captures the net impact of non-cash adjustments to legal reserves, accounting for both the creation of new r...
Used by large-cap companies in litigious industries to manage and report legal exposure.
abbv_litigation_reserve_adjustments| Q4 '21 | Q3 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $142.00M | $71.00M | -$87.00M | -$238.00M | -$12.00M | $39.00M | $314.00M | $167.00M | -$729.00M | -$21.00M | -$319.00M | $150.00M |
| QoQ Change | — | -50.0% | -222.5% | -173.6% | +95.0% | +425.0% | +705.1% | -46.8% | -536.5% | +97.1% | <-999% | +147.0% |
| YoY Change | — | — | -222.5% | — | — | — | +460.9% | +170.2% | <-999% | -153.8% | -201.6% | +120.6% |